4,897
Views
15
CrossRef citations to date
0
Altmetric
Review

Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology

, , , , , & show all
Pages 569-587 | Received 20 Feb 2019, Accepted 03 May 2019, Published online: 20 Jun 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.